For glioma molecular profiling all these companies offer probes for detection of 1p/19q-codeletion, EGFR amplification, and PTEN. Despite missing probes for the detection of CDKN2A deletion, Abnova developed BRAF V600E diagnostic probes. This evidence concerns the gene CDKN2A and central nervous system cancer.